Cancer Drugs: MABs, MIBs, MIDs, NABs, and NIBs

the first monoclonal antibody, rituximab (MAB) was approved for non-Hodgkin lymphoma in 1997, Every living cell has a critical enzyme called Protease. The first Protease inhibitor (PI) was approved   for myeloma in 2003. It is bortezomib (ZOMIB) The first immuno-modulatory drug, lenalidomide ( IMID) was approved for myeloma in 2006. Remember Thalidomide. NAB isContinue reading “Cancer Drugs: MABs, MIBs, MIDs, NABs, and NIBs”